• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性血管内皮生长因子受体-1 和 -2、其配体和其他因素在伴有黄斑水肿的视网膜分支静脉阻塞中的作用。

Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.

机构信息

Department of Ophthalmology, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan.

Department of Ophthalmology, Medical Center East, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Invest Ophthalmol Vis Sci. 2014 Jun 3;55(6):3878-85. doi: 10.1167/iovs.14-13961.

DOI:10.1167/iovs.14-13961
PMID:24894397
Abstract

PURPOSE

To evaluate the association between multiple factors in aqueous humor and the severity of macular edema in patients with branch retinal vein occlusion (BRVO).

METHODS

We measured the aqueous humor levels of 11 factors (including vascular endothelial growth factor receptors, growth factors, and inflammatory factors) in BRVO patients with macular edema and in cataract patients as controls. Aqueous humor samples were obtained from 40 patients (31 patients with BRVO and 9 with cataract). Then the levels of vascular endothelial growth factor (VEGF), soluble VEGF receptor (sVEGFR)-1, sVEGFR-2, placental growth factor (PlGF), soluble intercellular adhesion molecule (sICAM)-1, monocyte chemotactic protein (MCP)-1, platelet-derived growth factor (PDGF)-AA, interleukin (IL)-6, IL-8, IL-12(p70), and IL-13 were measured by the suspension array method. Macular edema was examined by optical coherence tomography, and its severity was determined from the central macular thickness (CMT), neurosensory retinal thickness (TNeuro), and subfoveal serous retinal thickness (SRT).

RESULTS

Aqueous humor levels of growth factors, sVEGFR-1, sVEGFR-2, and inflammatory factors were significantly higher in eyes with BRVO than in control eyes. Aqueous levels of sVEGFR-1 and -2 were significantly correlated with the SRT, as well as with the levels of growth factors (PIGF and PDGF-AA) and various inflammatory factors (sICAM-1, MCP-1, IL-6, and IL-8). Levels of the growth factors (VEGF, PlGF, and PDGF-AA) were also significantly correlated with each other.

CONCLUSIONS

These findings suggest the importance of the cytokine network in BRVO patients, and may contribute to understanding the mechanism of macular edema associated with BRVO and to development of new treatments.

摘要

目的

评估在伴有黄斑水肿的视网膜分支静脉阻塞(BRVO)患者的房水中多种因素与黄斑水肿严重程度之间的关系。

方法

我们测量了 40 例患者(31 例 BRVO 患者和 9 例白内障患者)房水中 11 种因子(包括血管内皮生长因子受体、生长因子和炎症因子)的水平。BRVO 伴黄斑水肿患者和白内障对照患者的房水样本均来自于玻璃体切割术。然后通过悬浮阵列法测量血管内皮生长因子(VEGF)、可溶性血管内皮生长因子受体(sVEGFR)-1、sVEGFR-2、胎盘生长因子(PlGF)、可溶性细胞间黏附分子(sICAM)-1、单核细胞趋化蛋白(MCP)-1、血小板衍生生长因子(PDGF)-AA、白细胞介素(IL)-6、IL-8、IL-12(p70)和 IL-13 的水平。使用光学相干断层扫描(OCT)检查黄斑水肿,从中央黄斑厚度(CMT)、神经感觉视网膜厚度(TNeuro)和中心凹下浆液性视网膜厚度(SRT)确定其严重程度。

结果

与对照组相比,BRVO 眼房水中的生长因子、sVEGFR-1、sVEGFR-2 和炎症因子水平明显升高。sVEGFR-1 和 sVEGFR-2 水平与 SRT 以及生长因子(PlGF 和 PDGF-AA)和各种炎症因子(sICAM-1、MCP-1、IL-6 和 IL-8)水平显著相关。生长因子(VEGF、PlGF 和 PDGF-AA)水平也相互显著相关。

结论

这些发现表明细胞因子网络在 BRVO 患者中的重要性,可能有助于了解与 BRVO 相关的黄斑水肿的发病机制,并有助于开发新的治疗方法。

相似文献

1
Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.可溶性血管内皮生长因子受体-1 和 -2、其配体和其他因素在伴有黄斑水肿的视网膜分支静脉阻塞中的作用。
Invest Ophthalmol Vis Sci. 2014 Jun 3;55(6):3878-85. doi: 10.1167/iovs.14-13961.
2
Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.可溶性血管内皮生长因子受体信号传导及其他因子或细胞因子在黄斑水肿型视网膜中央静脉阻塞中的作用
Invest Ophthalmol Vis Sci. 2015 Jan 29;56(2):1122-8. doi: 10.1167/iovs.14-15789.
3
Association of inflammatory factors with macular edema in branch retinal vein occlusion.炎症因子与视网膜分支静脉阻塞黄斑水肿的相关性研究。
JAMA Ophthalmol. 2013 Feb;131(2):160-5. doi: 10.1001/2013.jamaophthalmol.228.
4
Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.视网膜分支静脉阻塞伴黄斑水肿患者的可溶性血管内皮生长因子受体-2 和炎症因子。
Am J Ophthalmol. 2011 Oct;152(4):669-677.e1. doi: 10.1016/j.ajo.2011.04.006. Epub 2011 Jul 2.
5
Aqueous soluble vascular endothelial growth factor receptor-2 in macular edema with branch retinal vein occlusion.伴有分支视网膜静脉阻塞的黄斑水肿中的水溶性血管内皮生长因子受体-2。
Curr Eye Res. 2013 Dec;38(12):1288-90. doi: 10.3109/02713683.2013.821135. Epub 2013 Aug 23.
6
POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION.贝伐单抗治疗视网膜分支静脉阻塞性黄斑水肿的可能分子基础
Retina. 2016 Sep;36(9):1718-25. doi: 10.1097/IAE.0000000000000983.
7
Pentraxin 3 and other inflammatory factors in central retinal vein occlusion and macular edema.Pentraxin 3 及其他炎症因子与视网膜中央静脉阻塞及黄斑水肿。
Retina. 2014 Feb;34(2):352-9. doi: 10.1097/IAE.0b013e3182993d74.
8
Vascular endothelial growth factor receptor-2 in macular oedema with retinal vein occlusion.血管内皮生长因子受体-2 在视网膜静脉阻塞伴黄斑水肿中的作用。
Ophthalmic Res. 2012;48(1):56-8. doi: 10.1159/000336020. Epub 2012 Mar 9.
9
Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.玻璃体内贝伐单抗与大分支和黄斑分支视网膜静脉阻塞的细胞因子水平。
Ophthalmologica. 2011;225(3):150-4. doi: 10.1159/000322364. Epub 2010 Dec 9.
10
Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.每月玻璃体腔内注射贝伐单抗治疗黄斑水肿相关性视网膜静脉阻塞后的细胞因子动力学
Ophthalmic Res. 2016;56(4):207-214. doi: 10.1159/000445211. Epub 2016 May 4.

引用本文的文献

1
Multimodal data-driven approaches in retinal vein occlusion: A narrative review integrating machine learning and bioinformatics.视网膜静脉阻塞中多模态数据驱动方法:结合机器学习和生物信息学的叙述性综述
Adv Ophthalmol Pract Res. 2025 Jul 14;5(4):235-244. doi: 10.1016/j.aopr.2025.07.002. eCollection 2025 Nov-Dec.
2
Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product.生物类似药候选产品ABP 938与阿柏西普参比产品的非临床相似性
Ophthalmol Ther. 2025 Jan;14(1):85-101. doi: 10.1007/s40123-024-01043-5. Epub 2024 Nov 6.
3
Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies.
用于预测视网膜静脉阻塞相关性黄斑水肿治疗反应的光学相干断层扫描、多模态成像和细胞因子标志物的综合评估:抗血管内皮生长因子和类固醇疗法的比较性综述
Diagnostics (Basel). 2024 Sep 7;14(17):1983. doi: 10.3390/diagnostics14171983.
4
Effect of a novel tyrosine kinase inhibitor nintedanib on bFGF and VEGF concentrations in a rabbit retinal vein occlusion model.新型酪氨酸激酶抑制剂尼达尼布对兔视网膜静脉阻塞模型中碱性成纤维细胞生长因子和血管内皮生长因子浓度的影响。
Int J Ophthalmol. 2023 Sep 18;16(9):1450-1455. doi: 10.18240/ijo.2023.09.11. eCollection 2023.
5
Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion.视网膜分支静脉阻塞性黄斑水肿采用抗血管内皮生长因子疗法联合或不联合初始类固醇疗法的研究
Clin Ophthalmol. 2023 Aug 9;17:2267-2275. doi: 10.2147/OPTH.S418843. eCollection 2023.
6
Increased intraocular inflammation in retinal vein occlusion is independent of circulating immune mediators and is involved in retinal oedema.视网膜静脉阻塞时眼内炎症增加与循环免疫介质无关,且参与视网膜水肿的形成。
Front Neurosci. 2023 Jul 24;17:1186025. doi: 10.3389/fnins.2023.1186025. eCollection 2023.
7
Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema.玻璃体内注射雷珠单抗对伴有黄斑水肿的视网膜分支静脉阻塞患者外周视网膜微循环及细胞因子的影响。
Medicina (Kaunas). 2023 May 30;59(6):1053. doi: 10.3390/medicina59061053.
8
Changes in Aqueous and Vitreous Inflammatory Cytokine Levels in Retinal Vein Occlusion: A Systematic Review and Meta-analysis.视网膜静脉阻塞中房水和玻璃体内炎性细胞因子水平的变化:一项系统评价和荟萃分析。
J Vitreoretin Dis. 2019 Oct 31;4(1):36-64. doi: 10.1177/2474126419880391. eCollection 2020 Jan-Feb.
9
A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics.视网膜静脉阻塞中眼内生物分子的综述:迈向伴随诊断的潜在生物标志物
Front Pharmacol. 2022 Apr 26;13:859951. doi: 10.3389/fphar.2022.859951. eCollection 2022.
10
Role of ICAM-1 in impaired retinal circulation in rhegmatogenous retinal detachment.细胞间黏附分子-1 在孔源性视网膜脱离导致视网膜循环障碍中的作用。
Sci Rep. 2021 Jul 28;11(1):15393. doi: 10.1038/s41598-021-94993-w.